Articles liés à Advances in Multiple Sclerosis and Experimental Demyelinatin...

Advances in Multiple Sclerosis and Experimental Demyelinating Diseases - Couverture rigide

Livre 32 sur 258: Current Topics in Microbiology and Immunology
 
9783540736769: Advances in Multiple Sclerosis and Experimental Demyelinating Diseases

Synopsis

Controversy still exists regarding how early disease-modifying agents (DMA) should be commenced and whether all patients with relapsing-remitting MS should in fact be treated. To answer these questions, it is also important to know the natural history of the disease. MS affects nearly 400,000 people in the United States. With their novel, multifaceted approach to basic science, the authors of this book offer help to clinicians and hope to patients.

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.